Unknown

Dataset Information

0

Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.


ABSTRACT: The major barrier to HIV-1 cure is the persistence of latent provirus, which is not eradicated by antiretroviral therapy. The "shock and kill" approach entails stimulating viral production with latency-reversing agents followed by the killing of cells actively producing the virus by immune clearance. However, this approach does not induce all intact proviruses, leaving a residual reservoir. CRISPR/Cas9 has been utilized to excise integrated Human Immunodeficiency Virus (HIV) DNA from infected cells in an RNA-guided, sequence-specific manner. Here, we seek to epigenetically silence the proviral DNA by introducing nuclease-deficient disabled Cas9 (dCas9) coupled with a transcriptional repressor domain derived from Kruppel-associated box (KRAB). We show that specific guide RNAs (gRNAs) and dCas9-KRAB repress HIV-1 transcription and reactivation of latent HIV-1 provirus. This repression is correlated with chromatin changes, including decreased H3 histone acetylation and increased histone H3 lysine 9 trimethylation, histone marks that are associated with transcriptional repression. dCas9-KRAB-mediated inhibition of HIV-1 transcription suggests that CRISPR can be engineered as a tool for block-and-lock strategies.

SUBMITTER: Olson A 

PROVIDER: S-EPMC7600714 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeted Chromatinization and Repression of HIV-1 Provirus Transcription with Repurposed CRISPR/Cas9.

Olson Alex A   Basukala Binita B   Lee Seunghee S   Gagne Matthew M   Wong Wilson W WW   Henderson Andrew J AJ  

Viruses 20201012 10


The major barrier to HIV-1 cure is the persistence of latent provirus, which is not eradicated by antiretroviral therapy. The "shock and kill" approach entails stimulating viral production with latency-reversing agents followed by the killing of cells actively producing the virus by immune clearance. However, this approach does not induce all intact proviruses, leaving a residual reservoir. CRISPR/Cas9 has been utilized to excise integrated Human Immunodeficiency Virus (HIV) DNA from infected ce  ...[more]

Similar Datasets

| S-EPMC3752613 | biostudies-other
| S-EPMC6924169 | biostudies-literature
| S-EPMC6318701 | biostudies-literature
| S-EPMC3813849 | biostudies-other
2016-08-20 | E-GEOD-72259 | biostudies-arrayexpress
| S-EPMC4920395 | biostudies-literature
| S-EPMC5916876 | biostudies-other
| S-EPMC5701507 | biostudies-literature
| S-EPMC5542798 | biostudies-other
| S-EPMC5436839 | biostudies-literature